aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Cansortium Inc., founded in 2018 and headquartered in Miami, Florida, is a medical cannabis producer and seller operating under the Fluent brand. The company focuses on providing high-quality medical cannabis products in Florida, Pennsylvania, and Texas. Their product range includes oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles. Additionally, Cansortium Inc. offers various third-party branded medical cannabis products, aiming to improve patient wellness through innovative and accessible cannabis solutions.
Notable figures affiliated with Cansortium Inc. include key industry experts and investors who have supported the company's growth and market penetration. The company has achieved significant milestones, such as establishing a strong presence in three major states and expanding its product offerings to meet diverse patient needs. Cansortium Inc.'s impact is marked by its commitment to quality and patient care, contributing to the broader acceptance and integration of medical cannabis in healthcare.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Cannabis
Technology
Cannabis
Tags
Healthtech
Model Types
Retail
Revenue Type(s)
Transactional
Customer Type(s)
Consumers
Geographic Exposure
United States
Where is CansortiumInc’s headquarters located?
CansortiumInc’s headquarters is located in Miami, FL, US.
CansortiumInc Address
82 NE 26th St
Miami,
Florida
33137
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts